GrahamB wrote: G1945V wrote: GB, ..... would you agree that if VMS 3.0 can detect Atrial Dysfunction it could very well detect inflammation of the heart muscle (myocarditis) that typically occurs in patients with advanced COVID-19 disease.
jmo
G1945V
Clearly, myocarditis can be linked to dysfunction, and in turn heart failure.
The point is, not whether there is some indirect finding in a paediatric study that could be applied to Covid cardiac monitoring (which is in adults)...
If you want to study monitoring of the heart, in patients with Covid, you would design a study and do it -in COVID patients with cardiac disease.
Furthermore, if you deemed that VPTs instrument, and knowledge based reconstruction, could revolutionize this monitoring, why are we not reading about this from any cardiologists, and we are only making these indirect suppositions on a Internet stock board for a OTC stock on the TSX venture.
The Bottom line is that this technology is not being adopted yet, and certainly not being recommended and adopted to this point, to my knowledge.
If you can provide a reference, to a cardiology organization, or a hospital that is embracing this technology, please do so. Otherwise this is speculation, that is not based on facts.
Speculations are quite rampant on this board, including predictions of share price that could be one dollar, two dollars, three dollars, even $12, all of which without any revenue basis, or mathematical support.